Key Highlights

  • Shares are trading 14.66% lower at $2.27 on Thursday, October 29, 2026, from an implied prior close near $2.66 (calculated).
  • Third-quarter net operating revenues declined 10.7% to $2.757 billion from $3.087 billion a year earlier.
  • The quarterly diluted loss was $0.63 per share, compared with earnings of $0.96 per share in the same quarter a year ago.
  • Adjusted EBITDA fell 25.5% to $280 million from $376 million.
  • Revised 2026 adjusted EBITDA guidance is $1.225 billion to $1.275 billion, under the $1.30 billion to $1.375 billion range in place before the report.

Community Health Earnings: What Pushed Shares 14.66% Lower After a Third-Quarter Loss?

Community Health Systems (NYSE:CYH) shares are trading 14.66% lower at $2.27 on Thursday, October 29, 2026, which implies a prior close near $2.66 (calculated). The move follows third-quarter results released after the close on Wednesday, October 28, 2026, for the period ended September 30. Net operating revenues dropped 10.7% to $2.757 billion, and the company posted a diluted loss of $0.63 per share, or $0.48 excluding adjusting items.

The company runs acute care hospitals and related outpatient services in communities across the United States. The sub-$5 share price reflects a heavily indebted business, and the stock had traded near $2.76 in the week before the report.

Guidance Reduction: How Far Did the 2026 Targets Come Down?

Revised 2026 guidance calls for net operating revenues of $11.3 billion to $11.5 billion, under the $11.4 billion to $11.6 billion range in place before the report. Adjusted EBITDA is now expected at $1.225 billion to $1.275 billion, versus $1.30 billion to $1.375 billion previously, which cuts the midpoint by about $87.5 million (calculated). The diluted loss per share is guided at $1.60 to $1.70.

Market estimates for the quarter had pointed to a loss of about $0.22 per share on revenue near $2.78 billion, so the reported $0.63 loss was wider than expected. A year earlier the company earned $0.96 per share on $3.087 billion of revenue. Adjusted EBITDA of $280 million compared with $376 million, a fall of 25.5%.

The estimated impact from the expiration of enhanced ACA subsidies had been raised to $50 million to $75 million before the report, from $20 million to $30 million a quarter earlier.

Divestitures and Admissions: What Explains the Revenue Decline?

The revenue decline reflects hospital divestitures, with ten hospitals sold or moved out of the portfolio during 2026, the latest effective October 1. Consolidated admissions dropped 12.3% and consolidated adjusted admissions dropped 11.9%.

On a same-store basis, revenues grew 3.8%, admissions grew 2.2% and adjusted admissions grew 3.6%. Operating cash flow improved to $155 million from $70 million a year earlier.

Second-quarter results, reported on July 22, 2026, showed a loss of $0.19 per share on $2.83 billion of revenue. Roughly half of that quarter's same-store admissions growth came from uninsured and self-pay patients.

What to Watch Next: Liquidity, Debt and the Arkansas Hospital Sale

Cash was $155 million on September 30, down from $260 million at the end of 2025, while long-term debt was $9.568 billion. The asset-based credit facility had no borrowings and about $745 million of additional capacity. Investors can follow the agreement to sell four Arkansas hospitals for $110 million, the earnings call that follows the release, and whether the reduced guidance holds through the fourth quarter.